Goserelin · 2022-12-30
ClinicalTrials.gov record NCT00004124
Completed at observation.
Open attributed record →ClinicalTrials.gov registry-update year
71 selected ClinicalTrials.gov records carrying a 2022 registry-update date. This is selective historical coverage, not a complete trial inventory or an assessment of study quality.
71 selected records.
31 connected profiles.
69 retained records.
Attributed registry records
Goserelin · 2022-12-30
Completed at observation.
Open attributed record →Oxytocin · 2022-12-20
Completed at observation.
Open attributed record →Desmopressin · 2022-12-15
Completed at observation.
Open attributed record →Terlipressin · 2022-11-29
Completed at observation.
Open attributed record →Teriparatide · 2022-11-29
Completed at observation.
Open attributed record →Terlipressin · 2022-11-29
Completed at observation.
Open attributed record →Liraglutide · 2022-11-25
Completed at observation.
Open attributed record →Liraglutide · 2022-11-17
Completed at observation.
Open attributed record →Carfilzomib · 2022-11-14
Completed at observation.
Open attributed record →Oxytocin · 2022-11-10
Completed at observation.
Open attributed record →Teriparatide · 2022-11-10
Completed at observation.
Open attributed record →Lutetium Lu 177 dotatate · 2022-11-08
Completed at observation.
Open attributed record →Glucagon · 2022-11-04
Completed at observation.
Open attributed record →Leuprolide · 2022-10-18
Completed at observation.
Open attributed record →Lanreotide · 2022-10-14
Completed at observation.
Open attributed record →Teduglutide · 2022-10-04
Completed at observation.
Open attributed record →Tesamorelin · 2022-09-30
Completed at observation.
Open attributed record →Carfilzomib · 2022-09-27
Completed at observation.
Open attributed record →Carfilzomib · 2022-09-23
Completed at observation.
Open attributed record →Carfilzomib · 2022-09-21
Completed at observation.
Open attributed record →Dalbavancin · 2022-09-21
Completed at observation.
Open attributed record →Exenatide · 2022-09-16
Completed at observation.
Open attributed record →Difelikefalin · 2022-09-08
Completed at observation.
Open attributed record →Dasiglucagon · 2022-09-07
Completed at observation.
Open attributed record →Glucagon · 2022-09-06
Completed at observation.
Open attributed record →Octreotide · 2022-08-04
Completed at observation.
Open attributed record →Leuprolide · 2022-08-04
Completed at observation.
Open attributed record →Glucagon · 2022-08-03
Completed at observation.
Open attributed record →Icatibant · 2022-08-03
Completed at observation.
Open attributed record →Leuprolide · 2022-07-26
Completed at observation.
Open attributed record →Avexitide · 2022-07-18
Completed at observation.
Open attributed record →Zilucoplan · 2022-06-29
Completed at observation.
Open attributed record →Glucagon · 2022-06-28
Current at observation.
Open attributed record →Leuprolide · 2022-06-21
Completed at observation.
Open attributed record →Goserelin · 2022-06-15
Completed at observation.
Open attributed record →Teduglutide · 2022-06-14
Completed at observation.
Open attributed record →Exenatide · 2022-06-07
Completed at observation.
Open attributed record →Degarelix · 2022-06-06
Completed at observation.
Open attributed record →Oxytocin · 2022-06-01
Completed at observation.
Open attributed record →Carfilzomib · 2022-05-25
Completed at observation.
Open attributed record →Teduglutide · 2022-05-25
Completed at observation.
Open attributed record →Teduglutide · 2022-05-24
Completed at observation.
Open attributed record →Octreotide · 2022-05-23
Completed at observation.
Open attributed record →Octreotide · 2022-05-13
Completed at observation.
Open attributed record →Exenatide · 2022-05-05
Completed at observation.
Open attributed record →Oxytocin · 2022-05-04
Completed at observation.
Open attributed record →Difelikefalin · 2022-04-26
Completed at observation.
Open attributed record →Difelikefalin · 2022-04-26
Completed at observation.
Open attributed record →Leuprolide · 2022-04-19
Completed at observation.
Open attributed record →Liraglutide · 2022-04-12
Completed at observation.
Open attributed record →Lutetium Lu 177 dotatate · 2022-04-04
Completed at observation.
Open attributed record →Bremelanotide · 2022-04-04
Completed at observation.
Open attributed record →Teriparatide · 2022-04-01
Completed at observation.
Open attributed record →Icatibant · 2022-03-29
Completed at observation.
Open attributed record →Pegcetacoplan · 2022-03-25
Completed at observation.
Open attributed record →Etelcalcetide · 2022-03-23
Completed at observation.
Open attributed record →Cerebrolysin · 2022-03-21
Completed at observation.
Open attributed record →Lanreotide · 2022-03-16
Current at observation.
Open attributed record →Desmopressin · 2022-03-02
Completed at observation.
Open attributed record →Calcitonin salmon · 2022-02-21
Completed at observation.
Open attributed record →Oxytocin · 2022-02-11
Completed at observation.
Open attributed record →Ganirelix · 2022-02-03
Completed at observation.
Open attributed record →Teduglutide · 2022-02-02
Completed at observation.
Open attributed record →Goserelin · 2022-01-21
Completed at observation.
Open attributed record →Semaglutide · 2022-01-19
Completed at observation.
Open attributed record →Leuprolide · 2022-01-18
Completed at observation.
Open attributed record →Degarelix · 2022-01-13
Completed at observation.
Open attributed record →Ganirelix · 2022-01-11
Completed at observation.
Open attributed record →Leuprolide · 2022-01-10
Completed at observation.
Open attributed record →Setmelanotide · 2022-01-04
Completed at observation.
Open attributed record →Thymosin alpha-1 · 2022-01-03
Completed at observation.
Open attributed record →